PARSIPPANY, N.J., April 27, 2012 /PRNewswire/ -- Watson Pharmaceuticals, Inc.

SYDNEY and BEDMINSTER, N.J., April 26, 2012 /PRNewswire/ -- QRxPharma (ASX: QRX and OTCQX: QRXPY) is pleased to report that its US commercialisation partner for MoxDuo IR, Actavis, is to be

BEDMINSTER, N.J.

MORRISTOWN, N.J., Dec.

SYDNEY and BEDMINSTER, N.J., Dec.